Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 421931, 13 pages
http://dx.doi.org/10.1155/2014/421931
Research Article

Gastroretentive Pulsatile Release Tablets of Lercanidipine HCl: Development, Statistical Optimization, and In Vitro and In Vivo Evaluation

1Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka 576104, India
2Formulation Development, Centre of Excellence, Unichem Laboratories Ltd., Goa 403511, India

Received 31 July 2014; Revised 31 October 2014; Accepted 3 November 2014; Published 26 November 2014

Academic Editor: Vimon Tantishaiyakul

Copyright © 2014 Gagganapalli Santhoshi Reddy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Touitou and B. W. Barry, Enhancement in Drug Delivery, CRC Press, New York, NY, USA, 2010.
  2. B. N. Singh and K. H. Kim, “Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention,” Journal of Controlled Release, vol. 63, no. 3, pp. 235–259, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. K. C. Waterman, “A critical review of gastric retentive controlled drug delivery,” Pharmaceutical Development and Technology, vol. 12, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. S. Tous, F. A. Mohammed, and M. A. Sayed, “Formulation and in vitro evaluation of nitrofurantoin floating matrix tablets,” Journal of Drug Delivery Science and Technology, vol. 16, no. 3, pp. 217–221, 2006. View at Google Scholar · View at Scopus
  5. S. Saisivam, M. Rahamath Ulla, and F. Shakeel, “Development of floating matrix tablets of losartan potassium: in vitro and in vivo evaluation,” Journal of Drug Delivery Science and Technology, vol. 23, no. 6, pp. 611–617, 2013. View at Google Scholar · View at Scopus
  6. Z. Khan, V. Pillay, Y. E. Choonara, and L. C. du Toit, “Drug delivery technologies for chronotherapeutic applications,” Pharmaceutical Development and Technology, vol. 14, no. 6, pp. 602–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. O. P. Ranjan, U. Y. Nayak, M. S. Reddy, S. J. Dengale, P. B. Musmade, and N. Udupa, “Optimization of chronomodulated delivery system coated with a blend of ethyl cellulose and eudragit L100 by central composite design: in vitro and in vivo evaluation,” Journal of Pharmaceutical Innovation, vol. 9, no. 2, pp. 95–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Y. Nayak, G. V. Shavi, Y. Nayak et al., “Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system,” Journal of Controlled Release, vol. 136, no. 2, pp. 125–131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. O. P. Ranjan, U. Y. Nayak, M. S. Reddy, S. J. Dengale, P. B. Musmade, and N. Udupa, “Osmotically controlled pulsatile release capsule of montelukast sodium for chronotherapy: statistical optimization, in vitro and in vivo evaluation,” Drug Delivery, vol. 21, no. 7, pp. 509–518, 2014. View at Publisher · View at Google Scholar
  10. I. Krogel and R. Bodmeier, “Floating or pulsatile drug delivery systems based on coated effervescent cores,” International Journal of Pharmaceutics, vol. 187, no. 2, pp. 175–184, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Roy and A. Shahiwala, “Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough,” European Journal of Pharmaceutical Sciences, vol. 37, no. 3-4, pp. 363–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Charde, M. Mudgal, L. Kumar, and R. Saha, “Development and evaluation of buccoadhesive controlled release tablets of lercanidipine,” AAPS PharmSciTech, vol. 9, no. 1, pp. 182–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Gasser, W. Klein, and H. Köppel, “Lercanidipine, a new third generation Ca-antagonist in the treatment of hypertension,” Journal of Clinical and Basic Cardiology, vol. 2, no. 2, pp. 169–174, 1999. View at Google Scholar · View at Scopus
  14. M. Dedhiya, S. Rastogi, and A. Chhettry, “Lercanidipine immediate release compositions,” Patent WO/2007/120135, 2007.
  15. S. Pandey, E. Chandekar, A. Wattamwar, S. Pandit, H. Joshee, and A. Patil, “Enhancement of wettability and in vitro dissolution properties of lercanidipine hydrochloride by solid dispersion technique,” Thai Journal of Pharmaceutical Sciences, vol. 36, no. 3, pp. 108–116, 2012. View at Google Scholar · View at Scopus
  16. S. Y. Lin and Y. Kawashima, “Current status and approaches to developing press-coated chronodelivery drug systems,” Journal of Controlled Release, vol. 157, no. 3, pp. 331–353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Jiménez-Castellanos, H. Zia, and C. T. Rhodes, “Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application,” International Journal of Pharmaceutics, vol. 105, no. 1, pp. 65–70, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. M. I. Tadros, “Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 74, no. 2, pp. 332–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Dorozyński, R. Jachowicz, P. Kulinowski et al., “The macromolecular polymers for the preparation of hydrodynamically balanced systems—methods of evaluation,” Drug Development and Industrial Pharmacy, vol. 30, no. 9, pp. 947–957, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Mutalik, P. Anju, K. Manoj, and A. N. Usha, “Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach,” International Journal of Pharmaceutics, vol. 350, no. 1-2, pp. 279–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Pharmacopoeia Indian, vol. 1, Government of India, Ministry of Health and Family Welfare, 2007.
  22. S. Mutalik, K. Manoj, M. S. Reddy et al., “Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies,” AAPS PharmSciTech, vol. 9, no. 2, pp. 651–659, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Tantishaiyakul, N. Kaewnopparat, and S. Ingkatawornwong, “Properties of solid dispersions of piroxicam in polyvinylpyrrolidone,” International Journal of Pharmaceutics, vol. 181, no. 2, pp. 143–151, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Muatlik, A. N. Usha, M. S. Reddy, A. K. Ranjith, and S. Pandey, “Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies,” Pakistan Journal of Pharmaceutical Sciences, vol. 20, no. 3, pp. 218–226, 2007. View at Google Scholar · View at Scopus
  25. M. A. Hassan, “Design and evaluation of a floating ranitidine tablet as a drug delivery system for oral application,” Journal of Drug Delivery Science and Technology, vol. 17, no. 2, pp. 125–128, 2007. View at Google Scholar · View at Scopus
  26. M. Rane, J. Parmar, S. Tiwari, and A. Rajabi-Siahboomi, “Application of polyethylene oxide in hydrophilic matrix tablets,” Pharma Times, vol. 45, no. 3, pp. 41–48, 2013. View at Google Scholar · View at Scopus
  27. E. M. Rudnic, B. A. Burnside, H. H. Flanner et al., “Soluble form osmotic dose delivery system,” US Patent no. 6514532, 2003.